PROHANCE Drug Patent Profile
✉ Email this page to a colleague
When do Prohance patents expire, and when can generic versions of Prohance launch?
Prohance is a drug marketed by Bracco and is included in two NDAs.
The generic ingredient in PROHANCE is gadoteridol. One supplier is listed for this compound. Additional details are available on the gadoteridol profile page.
Summary for PROHANCE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 36 |
Clinical Trials: | 9 |
Patent Applications: | 826 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for PROHANCE |
What excipients (inactive ingredients) are in PROHANCE? | PROHANCE excipients list |
DailyMed Link: | PROHANCE at DailyMed |
Recent Clinical Trials for PROHANCE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Alabama at Birmingham | Early Phase 1 |
University of Alabama at Birmingham | Phase 1 |
Bracco (Sponsor) | Phase 4 |
Pharmacology for PROHANCE
Drug Class | Paramagnetic Contrast Agent |
Mechanism of Action | Magnetic Resonance Contrast Activity |
Anatomical Therapeutic Chemical (ATC) Classes for PROHANCE
US Patents and Regulatory Information for PROHANCE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bracco | PROHANCE | gadoteridol | INJECTABLE;INJECTION | 020131-001 | Nov 16, 1992 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bracco | PROHANCE MULTIPACK | gadoteridol | INJECTABLE;INJECTION | 021489-001 | Oct 9, 2003 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PROHANCE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bracco | PROHANCE | gadoteridol | INJECTABLE;INJECTION | 020131-001 | Nov 16, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
Bracco | PROHANCE | gadoteridol | INJECTABLE;INJECTION | 020131-001 | Nov 16, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
Bracco | PROHANCE | gadoteridol | INJECTABLE;INJECTION | 020131-001 | Nov 16, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
Bracco | PROHANCE | gadoteridol | INJECTABLE;INJECTION | 020131-001 | Nov 16, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PROHANCE
See the table below for patents covering PROHANCE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | S6452764 | 1-SUBSTITUTED 1,4,7-TRISCARBOXYMETHYL-1,4,7,10- TETRAAZACYCLODODECANE AND ANALOGUE | ⤷ Try a Trial |
European Patent Office | 0232751 | 1-SUBSTITUTED-4,7,10-TRISCARBOXYMETHYL-1,4,7,10-TETRAAZACYCLODODECANE AND ANALOGS | ⤷ Try a Trial |
Japan | 2537502 | ⤷ Try a Trial | |
Mexico | 174467 | 1,4,7-TRISCARBOXIMETIL-1,4,7,10-TETRAAZACICLODO DECANO SUBSTITUIDO EN 1 Y COMPUESTOS ANALOGOS | ⤷ Try a Trial |
Japan | S62190175 | 1-SUBSTITUTED-1,4,7-TRISCARBOXYMETHYL-1,4,7,10- TETRAAZACYCLODODECANE AND ANALOGUE | ⤷ Try a Trial |
European Patent Office | 0292689 | 1,4,7-Triscarboxyméthyl-1,4,7,10-tétraazacyclododécane substitué et analogues (Substituted 1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclo-dodecane and analogs) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |